The Comprehensive Clinical Trials Unit at UCL


Publication: CCTU colleagues published in the Lancet

3 September 2016

"Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial"

Our colleagues Simon Clawson, Yvonne Sylvestre, Nicola Muirhead and Caroline Doré from the RAPS study have been published in the Lancet.

The paper is available to read on the CCTU website here.